Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

End-tidal Oxygen Can Reliably Predict the Arterial Partial Pressure of Oxygen Among Emergency Department Patients Undergoing Rapid Sequence Intubation

NCT03842306 is registered in ClinicalTrials.gov with New York City Health and Hospitals Corporation as lead sponsor.

NCT NCT03842306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03842306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
End-tidal Oxygen Can Reliably Predict the Arterial Partial Pressure of Oxygen Among Emergency Department Patients Undergoing Rapid Sequence Intubation
Lead sponsor
New York City Health and Hospitals Corporation
Phase
Observational
Overall status
Completed
Start date
October 15, 2017
Completion date
December 30, 2017
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intubation complication